510(k) device
SpaceOAR System
Boston Scientific Corporation · Hydrogel Spacer (OVB, Class II) · First FDA decision Aug 28, 2020, newest Aug 28, 2020Cancer radiation therapyProstate cancer
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
14
Naming "SpaceOAR"
MAUDE reports
2,072
Brand "SpaceOAR", since 2015
PubMed studies
121
Mentioning "SpaceOAR"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing SpaceOAR System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- SpaceOAR System510(k)
K202224 · Decided Aug 28, 2020 · 21 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "SpaceOAR", any status and sponsor, newest update first.
- Effectiveness of the SpaceOAR Vue System in Subjects With Prostate CancerPivotal-lookingActive, not recruiting
Boston Scientific CorporationPublic (BSX)
NCT04905069 · 500 participants · Start Dec 21, 2021 · Primary completion Dec 2027
Device: SpaceOAR Vue System · For: Prostate Cancer
Sites: Fort Myers, Florida; Tampa, Florida; Kansas City, Kansas · 30 sites in all
- SpaceIT Hydrogel System for Perirectal SpacingPivotal-lookingActive, not recruiting
Boston Scientific CorporationPublic (BSX)
NCT06451614 · 230 participants (planned) · Start Oct 30, 2024 · Primary completion Sep 30, 2026
Device: SpaceIT Hydrogel System; Commercially available Boston Scientific Spacer · For: Prostate Cancer
Sites: Laguna Hills, California; Los Angeles, California; Miami, Florida · 26 sites in all
Milton S. Hershey Medical CenterAcademic, hospital or other
NCT05650021 · 17 participants · Start Mar 8, 2024 · Primary completion Sep 15, 2025
Device: SpaceOAR Vue · For: Prostate Cancer
Sites: Hershey, Pennsylvania
11 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "SpaceOAR", and for the whole product code for context.
This brand
2,072 reports: 1,357 malfunction, 707 injury, 8 death
Whole product code OVB
2,186 reports: 1,382 malfunction, 794 injury, 10 death
Newest reports for this brand
- SpaceOAR SystemMalfunction
2124215-2026-57472 · Received Oct 29, 2026 · Event dated Oct 12, 2026
Device type: Hydrogel Spacer (OVB)
Device problem as coded: Malposition of Device
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- SpaceOAR VUE? System - 10mLMalfunction
2124215-2026-57709 · Received Oct 29, 2026 · Event dated Oct 1, 2026
Device type: Hydrogel Spacer (OVB)
Device problem as coded: Malposition of Device
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- SpaceOAR VUE SystemInjury
2124215-2026-57416 · Received Oct 28, 2026 · Event dated Oct 5, 2026
Device type: Hydrogel Spacer (OVB)
Device problem as coded: Malposition of Device
Patient problem as coded: Diarrhea; Ulcer; Constipation
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1002-2022 · Started Feb 24, 2022
Reason given: Users need to be aware that embolism is a possible adverse event associated with hydrogel misplacements. Updated IFU provides new procedural instructions, warnings and precautions that describe steps to verify correct placement of the hydrogel following implantation, as well as technique recommendations for the proper...
Cause as FDA categorized it: Labeling design · Device type: Hydrogel Spacer (OVB)
Published research
The most relevant PubMed records for "SpaceOAR"[tiab]. The summary above synthesizes these.
- Robot-assisted Laparoscopic Prostatectomy After SpaceOAR Placement.
Crisostomo-Wynne T, Lee K, Speir R · Urology · 2023Video-Audio Media
- Perineal Abscess Following SpaceOAR Insertion.
Azhar U, Lin J, Sayed R, et al. · Cureus · 2023Case Reports
- SpaceOAR hydrogel complications in prostate cancer.
Grewal H, Kedar R, Dhillon G, et al. · Br J Radiol · 2023Review
- Rectal perforation following SpaceOAR placement combined with permanent prostate brachytherapy.
Morita M, Tanabe M, Kinugawa C, et al. · IJU Case Rep · 2024Case Reports
- SpaceOAR Complication Affecting the Treatment of Prostate Cancer.
Hassan J, Kieft A, Miller S · Cureus · 2024Case Reports
- SpaceOAR hydrogel spacer in interstitial brachytherapy for intrapelvic recurrent endometrial cancer.
Takagawa Y, Itami J · BJR Case Rep · 2022Case Reports
- The case of the missing spacer!
Boerkamp A, De Robles MS · J Surg Case Rep · 2023Case Reports
- Complications and Influential Perioperative Factors Associated with SpaceOAR Hydrogel Placement.
Wang KR, Simhal RK, Clark CB, et al. · Adv Urol · 2024
- Rectal complications following SpaceOAR insertion after prior pelvic radiation.
Yates AH, Dempsey PJ, Power JW, et al. · BJR Case Rep · 2025Review
- Application of Hydrogel Spacer SpaceOAR Vue for Prostate Radiotherapy.
Hadigal SR, Gupta AK · Tomography · 2022Review
- SpaceOAR hydrogel complications in prostate cancer radiotherapy: a pictorial review.
Pohl M, Nakrour N, Aswani Y, et al. · Abdom Radiol (NY) · 2025Review
- Real-World Complications of the SpaceOAR Hydrogel Spacer: A Review of the Manufacturer and User Facility Device Experience Database.
Fernandez AM, Jones CP, Patel HV, et al. · Urology · 2024Review
Other devices of this type
Also filed under product code OVB.
- SpaceOAR SystemAugmenix, Inc. · De Novo 2018
- SpaceOAR Flex SystemBoston Scientific Corporation · 510(k) 2026
- SpaceOAR Vue System (SV-2101)Boston Scientific Corporation · 510(k) 2026
- BioProtect Balloon Implant SystemBioprotect, Ltd. · 510(k) 2023
- Barrigel Injectable GelPalette Life Sciences · 510(k) 2022
- SpaceOAR Vue HydrogelAugmenix, Inc. · 510(k) 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.